Shanghai Henlius Biotech Inc. is a leading biopharmaceutical company specializing in the development of innovative monoclonal antibody (mAb) drugs. As a pivotal player in the biotechnology industry, H... Shanghai Henlius Biotech Inc. is a leading biopharmaceutical company specializing in the development of innovative monoclonal antibody (mAb) drugs. As a pivotal player in the biotechnology industry, Henlius focuses on oncology, autoimmune diseases, and chronic disorders, aiming to provide affordable healthcare solutions through biosimilars and novel biologics. The company is renowned for its robust R&D capabilities and a comprehensive pipeline of drug candidates, targeting unmet medical needs. Henlius not only contributes to the healthcare sector by enhancing drug accessibility and affordability but also plays a crucial role in scientific advancements and therapeutic breakthroughs. With a strong presence in Asian and global markets, Shanghai Henlius Biotech Inc. remains committed to pioneering life-altering therapies and improving patient outcomes worldwide.
Pending data availability
EU Taxonomy Data missing for Shanghai Henlius Biotech
We haven’t collected EU Taxonomy data for Shanghai Henlius Biotech yet, or the company
hasn’t made it publicly available.